GlassScriptPhysician profile
Zenith Haq Alam
NPI 1770002958
$12,583.01
in general payments reported to CMS, 2019-2025
32 companies · $2,408 in 2025
The $2,408 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $111 · 2021: $737 · 2022: $2,011 · 2023: $4,258 · 2024: $2,956 · 2025: $2,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,687 · Grant: $1,398 · Travel and Lodging: $793 · Education: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,686.55 |
| Grant | $1,398.18 |
| Travel and Lodging | $792.65 |
| Education | $743.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,366.11 | 2022-2025 | General - Vascular Access, Watchman Flx, Rotapro |
| Abbott Laboratories | $1,282.28 | 2021-2024 | Ensite, Navitor, Perclose Prostyle |
| Medtronic, INC. | $1,063.13 | 2022-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Shockwave Medical, INC | $909.37 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $556.97 | 2021-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $515.44 | 2020-2025 | Wainua, Brilinta |
| Impulse Dynamics (USA) INC. | $454.15 | 2021-2023 | Optimizer |
| Angiodynamics, INC. | $310.51 | 2024-2025 | Angiovac, Alphavac |
| Penumbra, INC. | $252.28 | 2023-2024 | Indigo System |
| Cordis US Corp. | $251.61 | 2023 | Radial 360, Mynx Control |
| E.R. Squibb & Sons, L.L.C. | $230.97 | 2023-2025 | Camzyos, Eliquis |
| Chiesi USA, INC. | $215.28 | 2023-2025 | Kengreal |
| Allergan, INC. | $200.26 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $187.03 | 2021-2024 | |
| Reflow Medical INC | $180.84 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $180.12 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $175.07 | 2024-2025 | Opsumit, Uptravi |
| Astellas Pharma US INC | $165.99 | 2022 | |
| Edwards Lifesciences Corporation | $163.28 | 2024 | Mitris Resilia Mitral Valve |
| Cvrx, INC. | $147.82 | 2023 | Barostim Neo System |
| Inari Medical, INC. | $122.18 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $113.36 | 2022 | |
| Amgen INC. | $88.81 | 2021-2025 | Repatha |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Acist Medical Systems, INC. | $81.56 | 2025 | |
| Pfizer INC. | $63.41 | 2023-2024 | |
| Philips North America LLC | $58.82 | 2025 | Coronary Other |
| Bayer Healthcare Pharmaceuticals INC. | $58.44 | 2025 | |
| Terumo Medical Corporation | $39.09 | 2022 | |
| Scpharmaceuticals INC. | $24.13 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.75 | 2023 | Jardiance |
| Cardiva Medical, INC. | $17.83 | 2024 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zenith Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.